Want to see IH full AI Analyst Report?
iHuman (IH) Stock Statistics & Valuation Metrics
Total Valuation
iHuman has a market cap or net worth of $60.32M. The enterprise value is -$75.65M.
- Market Cap
- $60.32M
- Enterprise Value
- -$75.65M
Share Statistics
iHuman has 22,318,407 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,318,407
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
iHuman’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.21%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 6.21%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 1.45M
- Profits Per Employee
- 170.97K
- Employee Count
- 558
- Asset Turnover
- 0.59
- Inventory Turnover
- 12.12
Valuation Ratios
The current PE Ratio of iHuman is 3.29. iHuman’s PEG ratio is -0.04.
- PE Ratio
- 3.29
- PS Ratio
- 0.10
- PB Ratio
- 0.09
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.04
Income Statement
In the last 12 months, iHuman had revenue of 807.02M and earned 95.40M in profits. Earnings per share was 9.10.
- Revenue
- 807.02M
- Gross Profit
- 547.61M
- Operating Income
- 66.76M
- Pretax Income
- 101.79M
- Net Income
- 95.40M
- EBITDA
- 109.54M
- Earnings Per Share (EPS)
- 9.10
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
iHuman pays an annual dividend of $0.09, resulting in a dividend yield of 8.47%
- Dividend Per Share
- $0.09
- Dividend Yield
- 8.47%
- Payout Ratio
- 29.51%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 30.41%
Stock Price Statistics
- Beta
- 0.39
- 52-Week Price Change
- -55.81%
- 50-Day Moving Average
- 1.18
- 200-Day Moving Average
- 1.48
- Relative Strength Index (RSI)
- 52.87
- Average Volume (3m)
- 6,541
Important Dates
iHuman upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 29, 2026
- Next Earnings Date
- Dec 17, 2026
- Ex-Dividend Date
- Apr 17, 2025
Financial Position
iHuman as a current ratio of 3.57, with Debt / Equity ratio of 1.14%
- Current Ratio
- 3.57
- Quick Ratio
- 3.51
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -10.41
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, iHuman has paid 6.39M in taxes.
- Income Tax
- 6.39M
- Effective Tax Rate
- 0.06
Enterprise Valuation
iHuman EV to EBITDA ratio is -79.06, with an EV/FCF ratio of 0.00.
- EV to Sales
- -0.94
- EV to EBITDA
- -79.06
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
iHuman has $1.01B in cash and marketable securities with $8.33M in debt, giving a net cash position of $999.42M billion.
- Cash & Marketable Securities
- $1.01B
- Total Debt
- $8.33M
- Net Cash
- $999.42M
- Net Cash Per Share
- $44.78
- Tangible Book Value Per Share
- $79.88
Margins
Gross margin is 66.63%, with operating margin of -0.69%, and net profit margin of 3.18%.
- Gross Margin
- 66.63%
- Operating Margin
- -0.69%
- Pretax Margin
- 3.31%
- Net Profit Margin
- 3.18%
- EBITDA Margin
- 1.19%
- EBIT Margin
- 0.93%
Analyst Forecast
The average price target for iHuman is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -12.17%
- EPS Growth Forecast
- -78.28%
Scores
- Smart Score
- ―
- AI Score
- 73
